387 related articles for article (PubMed ID: 11091360)
1. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies.
Park-Wyllie L; Mazzotta P; Pastuszak A; Moretti ME; Beique L; Hunnisett L; Friesen MH; Jacobson S; Kasapinovic S; Chang D; Diav-Citrin O; Chitayat D; Nulman I; Einarson TR; Koren G
Teratology; 2000 Dec; 62(6):385-92. PubMed ID: 11091360
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids during pregnancy and oral clefts: a case-control study.
Rodríguez-Pinilla E; Martínez-Frías ML
Teratology; 1998 Jul; 58(1):2-5. PubMed ID: 9699238
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome following first trimester exposure to antihistamines: meta-analysis.
Seto A; Einarson T; Koren G
Am J Perinatol; 1997 Mar; 14(3):119-24. PubMed ID: 9259911
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study.
Gur C; Diav-Citrin O; Shechtman S; Arnon J; Ornoy A
Reprod Toxicol; 2004; 18(1):93-101. PubMed ID: 15013068
[TBL] [Abstract][Full Text] [Related]
7. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
[TBL] [Abstract][Full Text] [Related]
8. The safety of metoclopramide use in the first trimester of pregnancy.
Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
[TBL] [Abstract][Full Text] [Related]
9. First trimester exposure to corticosteroids and oral clefts.
Pradat P; Robert-Gnansia E; Di Tanna GL; Rosano A; Lisi A; Mastroiacovo P;
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):968-70. PubMed ID: 14745915
[TBL] [Abstract][Full Text] [Related]
10. Teratogenic potential of corticosteroids in humans.
Fraser FC; Sajoo A
Teratology; 1995 Jan; 51(1):45-6. PubMed ID: 7597656
[TBL] [Abstract][Full Text] [Related]
11. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies.
McKeigue PM; Lamm SH; Linn S; Kutcher JS
Teratology; 1994 Jul; 50(1):27-37. PubMed ID: 7974252
[TBL] [Abstract][Full Text] [Related]
12. The safety of oral hypoglycemic agents in the first trimester of pregnancy: a meta-analysis.
Gutzin SJ; Kozer E; Magee LA; Feig DS; Koren G
Can J Clin Pharmacol; 2003; 10(4):179-83. PubMed ID: 14712322
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
14. Maternal occupational exposure to solvents and congenital malformations: a prospective study in the general population.
Garlantézec R; Monfort C; Rouget F; Cordier S
Occup Environ Med; 2009 Jul; 66(7):456-63. PubMed ID: 19541806
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
16. Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations.
Queisser-Luft A; Eggers I; Stolz G; Kieninger-Baum D; Schlaefer K
Am J Med Genet; 1996 May; 63(1):268-76. PubMed ID: 8723120
[TBL] [Abstract][Full Text] [Related]
17. A population-based case-control study of the safety of oral anti-tuberculosis drug treatment during pregnancy.
Czeizel AE; Rockenbauer M; Olsen J; Sørensen HT
Int J Tuberc Lung Dis; 2001 Jun; 5(6):564-8. PubMed ID: 11409585
[TBL] [Abstract][Full Text] [Related]
18. Population-based case-control study of teratogenic potential of corticosteroids.
Czeizel AE; Rockenbauer M
Teratology; 1997 Nov; 56(5):335-40. PubMed ID: 9451758
[TBL] [Abstract][Full Text] [Related]
19. [Use of anticonvulsive drugs during pregnancy and the risk of malformations in the newborn: a meta-analysis].
Gutiérrez-Alvarez AM
Rev Neurol; 2003 Dec 1-15; 37(11):1022-8. PubMed ID: 14669141
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome of women exposed to azathioprine during pregnancy.
Goldstein LH; Dolinsky G; Greenberg R; Schaefer C; Cohen-Kerem R; Diav-Citrin O; Malm H; Reuvers-Lodewijks ME; Rost van Tonningen-van Driel MM; Arnon J; Ornoy A; Clementi M; Di Gianantonio E; Koren G; Braunstein R; Berkovitch M
Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):696-701. PubMed ID: 17847119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
